US2019023731A1PendingUtilityA1
Convergent processes for preparing macrolide antibacterial agents
Assignee: CEMPRA PHARMACEUTICALS INCPriority: Mar 15, 2013Filed: Feb 20, 2018Published: Jan 24, 2019
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
Inventors:David E. Pereira
C07H 17/08
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention described herein relates to processes for preparing ketolide antibacterial agents. In particular, the invention relates to intermediates and processes for preparing ketolides that include a 1,2,3-triazole substituted side chain.
Claims
exact text as granted — not AI-modified1 - 25 . (canceled)
26 . A composition comprising solithromycin that is substantially free of
wherein A-B is (CH 2 ) 4 .
27 . A compound of the formula:
wherein:
A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ;
B is saturated C 0 C 10 ; or B is unsaturated C 2 C 10 ; or
AB taken together is alkylene, alkenylene, cycloalkylene, or arylene;
C is hydrogen, halogen, hydroxy, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, and alkyl, alkoxy, heteroalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl, each of which is optionally substituted; and
R 100 is hydrogen or a hydroxyl protecting group.
28 . The compound of claim 27 wherein C is aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each of which is optionally substituted.
29 . The compound of claim 27 wherein A is CH 2 .
30 . The compound of claim 27 wherein B is (CH 2 ) n , and n is an integer from 2-6.
31 . The compound of claim 27 of the formula
32 . The compound of claim 27 of the formula
33 . The compound of claim 32 wherein R 100 is hydrogen.
34 . An intermediate of the formulae
wherein:
A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ;
B is saturated C 0 C 10 ; or B is unsaturated C 2 C 10 ; or
AB taken together is alkylene, alkenylene, cycloalkylene, or arylene;
C is hydrogen, halogen, hydroxy, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, and alkyl, alkoxy, heteroalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl, each of which is optionally substituted; or C is C P , where C P is a protected form of C;
R 100 is hydrogen or a hydroxyl protecting group; and
N P is NH 2 or protected amino.
35 . The intermediate of claim 34 wherein C is aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each of which is optionally substituted.
36 . The intermediate of claim 34 wherein A is CH 2 .
37 . The intermediate of claim 34 wherein B is (CH 2 ) n , and n is an integer from 2-6.
38 . The intermediate of claim 34 wherein B is (CH 2 ) n , and n is 2, 3, or
4 .
39 . The intermediate of claim 34 wherein R 100 is acyl.
40 . The intermediate of claim 34 of the formula
41 . The intermediate of claim 34 of the formula
42 . The intermediate of claim 34 of the formula
43 . The intermediate of claim 34 of the formula
44 . The intermediate of claim 34 of the formulaCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.